7 Cancer Researchers Selected as Pew-Stewart Scholars

Friday, June 14, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

PHILADELPHIA, June 14, 2019 /PRNewswire/ -- The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust announced today the 2019 class members of the Pew-Stewart Scholars Program for Cancer Research.

The seven early-career scholars who make up the 2019 class are spearheading innovative research efforts designed to find cures for cancer, with each receiving

a four-year grant to advance these initiatives. This is the sixth year that the Alexander and Margaret Stewart Trust has partnered with Pew to support researchers pursuing groundbreaking work focused on better understanding the origins, diagnosis, and treatment of cancer.

"Cancer is a complex, devastating disease that the medical and scientific communities are diligently working to understand and ultimately cure," said Rebecca W. Rimel, Pew's president and CEO. "Pew is proud to support researchers who have dedicated their careers to this noble cause." 

The class of 2019 is examining several promising areas of cancer research, including strategies to reprogram tumor-associated immune cells, investigate a mutant protein in lung cancer, and develop methods to treat acute myeloid leukemia, among other topics.  

"Curing cancer demands curiosity, ingenuity, and perseverance from researchers," said Peter M. Howley, M.D., chair of the Pew-Stewart national advisory committee. "This new class of scholars displays those traits, and I am eager to see what they can accomplish."

The 2019 Pew-Stewart Scholars for Cancer Research are:

Michel DuPage, Ph.D.University of California, BerkeleyDr. DuPage will investigate how the immune system is suppressed within the tumor microenvironment.

Luke Gilbert, Ph.D.University of California, San FranciscoDr. Gilbert will develop strategies to treat a form of acute myeloid leukemia that is associated with a mutation or deficiency in the TP53 protein.

Diana Hargreaves, Ph.D.Salk Institute for Biological StudiesDr. Hargreaves will explore how tumor-associated macrophages can be reprogrammed to treat cancer.

Piro Lito, M.D., Ph.D.Memorial Sloan Kettering Cancer CenterDr. Lito will investigate how mutant KRAS proteins drive lung cancer, aiming to identify novel therapies for this disease.

Chao Lu, Ph.D.Columbia UniversityDr. Lu will investigate how abnormalities in the way chromosomes are modified contribute to the development of cancer.

Stefani Spranger, Ph.D.Massachusetts Institute of TechnologyDr. Spranger will examine how the makeup of patients' tumor immune microenvironment contributes to their response to immunotherapy.

Gabriel D. Victora, Ph.D.The Rockefeller University Dr. Victora will characterize the dynamic interaction between different immune cell types as cancers develop and change over time.

The Pew Charitable Trusts is driven by the power of knowledge to solve today's most challenging problems. Learn more at pewtrusts.org.

Erin Davis, 202-540-6677, edavis@pewtrusts.org


Cision View original content:http://www.prnewswire.com/news-releases/7-cancer-researchers-selected-as-pew-stewart-scholars-300866578.html

SOURCE The Pew Charitable Trusts

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store